A Study on Drug-Drug Interaction of Esomeprazole and Anti-Diabetic Drugs
2010

Study on Drug Interaction Between Esomeprazole and Anti-Diabetic Drugs

Sample size: 36 publication Evidence: moderate

Author Information

Author(s): VKM Swamy, RS Setty, MM Shankaraiah, TM Jyothi, SV Rajendra

Primary Institution: S.C.S. College of Pharmacy, Harapanahalli

Hypothesis

Esomeprazole may influence the metabolism of sulfonylureas.

Conclusion

Therapeutic doses of esomeprazole do not influence hypoglycemia induced by sulfonylureas, but higher doses enhance the duration and peak of hypoglycemia.

Supporting Evidence

  • Esomeprazole at therapeutic doses did not influence hypoglycemia induced by sulfonylureas.
  • At a higher dose of 30 mg/kg, esomeprazole significantly enhanced the duration and peak of hypoglycemia.
  • The study involved 36 albino rats divided into 6 groups for testing.

Takeaway

This study looked at how a heartburn medicine called esomeprazole affects diabetes medications. It found that normal doses don't change how well the diabetes meds work, but very high doses can make their effects stronger.

Methodology

Albino rats were used to study the effects of esomeprazole on hypoglycemia induced by tolbutamide and glibenclamide over an 8-day period.

Limitations

The study was conducted on animals, which may not fully represent human responses.

Participant Demographics

Albino rats of either sex, weighing 150–250 g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.4103/0975-1483.71624

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication